We measure what matters
"We had a lot of discussions with people about going on them, but most of those people then offered to go on, or stay on, injections
Dwyer CJ, Ward NC, Pugliese A, Malek TR (2016) Promoting immune regulation in type 1 diabetes using low-dose interleukin-2
Already earning billions each quarter on their branded weight-loss medications, Novo Nordisk and Eli Lilly stand to gain even more if they can remove the shortage designation, and are ramping up production
53rd Annual Symposium on Fundamental Cancer Research: Genetic Mechanisms in Cancer Conference, 2000
T-scores differed significantly across groups (p 92% of participants completed surveys, with 61% completing all surveys.Over 90% of participants reported compliance with Mucinex each treatment week